Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review

Many drugs with different mechanisms of action and indications available on the market today are capable of inducing hepatotoxicity. Drug-induced liver injury (DILI) has been a treatment challenge nowadays as it was in the past. We searched Medline (via PubMed), CENTRAL, Science Citation Index Expan...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Mirjana Stanić Benić, Lana Nežić, Vesna Vujić-Aleksić, Liliana Mititelu-Tartau
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Subjects:	drug-induced liver injury hepatotoxicity treatment therapy toxic hepatitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.785790/full

Similar Items

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
by: Mercedes Robles-Díaz, et al.
Published: (2021-10-01)

Drug-induced liver injury: An overview and update
by: Yujie Wang, et al.
Published: (2023-04-01)

Factors affecting drug-induced liver injury: antithyroid drugs as instances
by: Reza Heidari, et al.
Published: (2014-09-01)

Drug-induced liver injury in association with antipsychotics
by: R. Zeiss, et al.
Published: (2022-06-01)

Drug-induced liver injury secondary to turmeric use
by: Ashika Ajitkumar, et al.
Published: (2023-04-01)

Drug Induced Liver Injury: A Descriptive Analyses of Histopathological Patterns and Clinical Outcomes
by: Chaitra Venkataswamy, et al.

Role of metabolic nuclear receptors in acute liver injury and drug-induced hepatotoxicity
by: Liangliang Nie, et al.
Published: (2025-10-01)

Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature
by: Andreas Rogalewski, et al.
Published: (2021-01-01)

Polymorphism of genes and drug-induced liver injury
by: P. Ye. Tkachenko, et al.
Published: (2013-09-01)

Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats
by: Hossein Niknahad, et al.
Published: (2016-12-01)

Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report
by: Harsha Moole, et al.
Published: (2015-10-01)

Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center
by: Dimitris Kounatidis, et al.
Published: (2025-03-01)

Inflammatory Bowel Disease Therapies and Acute Liver Injury
by: Roberto Catanzaro, et al.
Published: (2024-06-01)

Hepatotoxicity evaluation method through multiple-factor analysis using human pluripotent stem cell derived hepatic organoids
by: Dae-Seop Shin, et al.
Published: (2025-03-01)

Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive OverviewSummary
by: Guolin Li, et al.
Published: (2024-01-01)

Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb
Published: (2011-12-01)

Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
by: Bilal Niazi, et al.
Published: (2022-11-01)

Liver Injury Associated with Antituberculosis Medications
by: Syifa Mustika, et al.
Published: (2025-07-01)

ADEMETIONINE THERAPY IN CHRONIC LIVER DISEASES
by: N. V. TOPCHIY, et al.
Published: (2016-12-01)

Drug-Induced Liver Injury: Pattern Recognition and Future Directions
Published: (2016-01-01)

Influence of Antibiotics on Functionality and Viability of Liver Cells In Vitro
by: Sandra Doß, et al.
Published: (2022-10-01)

Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions
by: J.M. Pinazo-Bandera, et al.
Published: (2024-05-01)

Hepatotoxicity Associated with Adalimumab in Hidradenitis Suppurativa: A Report of Two Cases of Drug-Induced Liver Injury
by: Cristian Fernando Caballero-Linares, et al.
Published: (2025-07-01)

Profile of Drug-Induced Liver Injury Due to Antibiotics in Patients with Chronic Liver Disease
by: C M Neethu, et al.
Published: (2020-01-01)

Clinical Features of Anti-Tuberculosis Drug-Induced Liver Injury and Risk Factors for Severe Cases: A Retrospective Study in China
by: Zhang S, et al.
Published: (2025-04-01)

Drug induced liver injury: Pathogenesis, clinical features and monitoring
by: Ćurguz Ana, et al.
Published: (2016-01-01)

Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause
by: Goran Bokan, et al.
Published: (2023-08-01)

Advanced human liver models for the assessment of drug-induced liver injury
by: Seon Ju Mun, et al.
Published: (2022-07-01)

Rosuvastatin-induced acute hepatitis: Insights from clinical experience on drug-induced liver injury
by: Bhavya Poojary, et al.
Published: (2024-08-01)

Drug-Induced Liver Injury in Tuberculosis: Mechanisms of Development and Diagnostic Methods
by: D. S. Sukhanov, et al.
Published: (2023-02-01)

Drug-induced cholestasis: causative agents and challenges in diagnosis and management
by: Jose M. Pinazo-Bandera, et al.
Published: (2023-09-01)

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
by: Ana Barreira-Díaz, et al.
Published: (2024-05-01)

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe
by: O. Kirakosyan, et al.
Published: (2025-02-01)

Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
by: Emanuel Raschi, et al.
Published: (2019-10-01)

Semaglutide‐Induced Hepatic Injury: A Rare Case of Drug Induced Liver Injury
by: Rupayan Kundu, et al.
Published: (2025-08-01)

Clinical trials and the importance of biobanks in rare diseases
by: Nežić Lana, et al.
Published: (2018-01-01)

Allograft Injury Following Nandrolone and High‐Dose Dietary Supplements Use in a Liver Transplant Recipient: A Case Report
by: Mahnaz Sadat Hosseini, et al.
Published: (2025-08-01)

Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
by: Edmond Atallah, et al.
Published: (2023-10-01)

The Hepatoprotection Provided by Taurine and Glycine against Antineoplastic Drugs Induced Liver Injury in an Ex Vivo Model of Normothermic Recirculating Isolated Perfused Rat Liver
by: Reza Heidari, et al.
Published: (2016-03-01)

The Hepatoprotection Provided by Taurine and Glycine against Antineoplastic Drugs Induced Liver Injury in an Ex Vivo Model of Normothermic Recirculating Isolated Perfused Rat Liver
by: Reza Heidari, et al.
Published: (2016-02-01)